Basket | Login | Register

 
 
 
 

Dementia experts meet in Lausanne to discuss Alzheimer’s diagnosis

Wednesday 13 November 2019

The 2019 Lausanne Workshop is the 6th in a series, launched in 2014 as a response to the international call to action to stop dementia by 2025. Over the past five years, the Workshop has become a highly-curated platform for global Alzheimer’s stakeholders to identify challenges, set solution paths, measure progress and hold each other accountable to act. Lausanne VI was organised under the auspices of the Organisation for Economic Co-Operation and Development (OECD) and supported by The Global CEO Initiative on Alzheimer’s Disease (CEOi) and Alzheimer’s Disease International (ADI). The theme of the workshop was: “Preparing the Alzheimer’s Disease Ecosystem for a Timely, Accurate and Compassionate Diagnosis”.

Some announcements coming out of the meeting:

  • An initial working session will be held during the 50th WEF Annual Meeting, taking place on 21-24 January 2020, in Davos. The aim will be to find successful ways to stimulate finance; to improve preclinical research and drug development; to attract greater investment; and to develop biomarkers to support precision medicine.
  • A new AD Biomarker & Diagnostic Repository has been launched by ResearchersAgainstAlzheimer’s. It seeks to raise awareness and visibility regarding recent innovation; to enable the development of a clear pathway for these innovations to get to market; and to provide a solid foundation for a broader global blueprint of Alzheimer’s research and innovation: https://www.usagainstalzheimers.org/biomarkers
  • In collaboration with CEOi, the Duke-Margolis Center for Health Policy showcased an upcoming White Paper on Advancing Access Issues in AD, examining payment for future early-stage AD therapies.

Alzheimer Europe was represented at Lausanne VI by its Director, Jean Georges.

Pictured: The keynote speech at LausanneVI was given by Jim Daly, Minister for Mental Health and Older People, Ireland.

Options